Parkinson's drug pump could smooth out daily 'Off' episodes
Disease control
Completed
This study tests a new way to deliver levodopa—the main Parkinson's medication—through a continuous infusion under the skin. It is designed for people with Parkinson's who experience at least two hours of 'off' time each day, when symptoms return between oral doses. The trial wil…
Phase: PHASE2 • Sponsor: NeuroDerm Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC